Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Annals of Clinical and Translational Neurology
|
April 5, 2021
Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
Christoph Kessler, Lina M Serna-Higuita, Tim W Rattay, et al.
Neurobiology of Disease
|
February 28, 2016
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
Matteo Santoro, Walter Maetzler, Petros Stathakos, et al.
Plos One
|
March 4, 2016
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia
Walter Maetzler, Willy Deleersnijder, Valérie Hanssens, et al.
Annals of Clinical and Translational Neurology
|
February 16, 2022
Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4
Christoph Kessler, Lina Maria Serna-Higuita, Carlo Wilke, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 14, 2018
Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up
Florian Härtig, Marlene Ross, Nele Maria Dammeier, et al.
Scientific Reports
|
September 16, 2020
Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy
Tim W Rattay, Maren Rautenberg, Anne S Söhn, et al.
Neurology
|
June 19, 2016
Uniparental disomy of chromosome 16 unmasks recessive mutations of FA2H/SPG35 in 4 families
Anne S Soehn, Tim W Rattay, Stefanie Beck-Wödl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 3, 2017
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles
Stefanie Lerche, Claudia Schulte, Karin Srulijes, et al.
Journal of Neurology
|
October 27, 2020
PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study
Kathrin Gonsior, Gabriele Anna Kaucher, Patrik Pelz, et al.
BMC Neurology
|
August 23, 2023
Amantadine for NeuroenhaNcement in acutE patients Study - a protocol for a prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES)
Anna Hofmann, Corinna Blum, Constanze Single, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Annals of Clinical and Translational Neurology
|
April 5, 2021
Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
Christoph Kessler, Lina M Serna-Higuita, Tim W Rattay, et al.
Neurobiology of Disease
|
February 28, 2016
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
Matteo Santoro, Walter Maetzler, Petros Stathakos, et al.
Plos One
|
March 4, 2016
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia
Walter Maetzler, Willy Deleersnijder, Valérie Hanssens, et al.
Annals of Clinical and Translational Neurology
|
February 16, 2022
Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4
Christoph Kessler, Lina Maria Serna-Higuita, Carlo Wilke, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 14, 2018
Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up
Florian Härtig, Marlene Ross, Nele Maria Dammeier, et al.
Scientific Reports
|
September 16, 2020
Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy
Tim W Rattay, Maren Rautenberg, Anne S Söhn, et al.
Neurology
|
June 19, 2016
Uniparental disomy of chromosome 16 unmasks recessive mutations of FA2H/SPG35 in 4 families
Anne S Soehn, Tim W Rattay, Stefanie Beck-Wödl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 3, 2017
Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles
Stefanie Lerche, Claudia Schulte, Karin Srulijes, et al.
Journal of Neurology
|
October 27, 2020
PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study
Kathrin Gonsior, Gabriele Anna Kaucher, Patrik Pelz, et al.
BMC Neurology
|
August 23, 2023
Amantadine for NeuroenhaNcement in acutE patients Study - a protocol for a prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES)
Anna Hofmann, Corinna Blum, Constanze Single, et al.
Page
of 5